As the global economy recovers in 2021 and the supply of the industrial chain improves, the Natural Killer Cell Therapies market will undergo major changes. According to the latest research, the market size of the Natural Killer Cell Therapies industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Natural Killer Cell Therapies industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Natural Killer Cell Therapies market during the next few years. The global Natural Killer Cell Therapies market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Natural Killer Cell Therapies market can be split based on product types, major applications, and important regions as follows:

North America
Europe
Asia Pacific
Latin America

Player list
Celgene Corporation
Ziopharm Oncology Inc.
Fortress Biotech
Nkarta Therapeutics, Inc.
Fate Therapeutics
Affimed N.V.
NKTTherapeutics Inc.
Nantkwest Inc
Glycostem Therapeutics BV
Innate Pharma S.A.

Types list
NK Cell Therapies
NK Cell Directed Antibodies

Application list
Cancer
Gastrointestinal Diseases
lmmunoproliferative Disorders
Others